Method Development and Validation
Coriolis Pharma offers a wide range of analytical methods for different testing requirements. You decide whether you start your project with us using an existing Coriolis method, transferring your own method or developing a new method. Our expertise ranges from research and development support to rapid transfer of GMP-compliant, validated methods for formal GMP testing, ensuring efficient and high-quality analysis through the analytical method life cycle. Scientific expertise and flexibility are the key to our success.
Additional specialized equipment and methods tailored to your product can be added, transferred and developed upon request. Reach out for your tailored offer!
Tailored Setup of Analytical Methods under R&D and GMP

At Coriolis, we tailor our analytical method setup to align with your molecule’s characteristics and the product’s stage in the life cycle—from preclinical development through to commercialization. Our flexible approach ensures robust, phase-appropriate analytical support at every step.
Your Entry Points for Analytical Testing at Coriolis Pharma
Coriolis Method
We offer a broad range of Coriolis methods, which can be adapted to fit the specific requirements of each client’s product. This service provides a streamlined, ready-to-implement solution for rapid analytical deployment.
Client Method
For clients with established analytical procedures, we support the seamless transfer and setup of their product-specific methods into our systems, ensuring consistency and compliance throughout the process.
Method Development & Optimization
We develop and optimize product-specific analytical methods tailored to the unique properties of each product. This includes method development from scratch or refinement & optimization of existing methods to enhance performance and reliability.
Analytical Method Development, Qualification and Validation
For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.
Integrated Stability & Release Testing Services under R&D and GMP
We perform analytical testing, and stability studies under both R&D and GMP conditions to support product quality from development through commercialization. Tailored approaches ensure regulatory compliance, robust data generation, and seamless integration into your development strategy.
For R&D projects, our analytical services provide rapid and efficient support for your product development needs. High quality standards enable a seamless transfer to the GMP environments and can be integrated into formulation and drug product development services.
In GMP settings, our services include compliant release and stability testing services designed to ensure product consistency and readiness for clinical and commercial supply. Validated methods and controlled storage conditions guarantee reliable results that meet global regulatory standards.
The Analytical Basis for GMP Testing Starts in R&D
A comprehensive portfolio of analytical techniques and instrument types paired with decades of experience in developing tailored solutions make Coriolis the ideal service partner already starting in pre-clinical development.
Flexible R&D Analytical Support
Our non-GMP analytical services provide a flexible and efficient pathway from early-stage development to late-phase and beyond. Designed to accelerate progress without compromising scientific rigor, this track supports method implementation, development and qualification ahead of transfer to a GMP environment.
-
Our experts ensure the swift and efficient setup of analytical methods under R&D enabling the rapid start of your development or testing activities. This includes adapting existing protocols and a performance check with your specific molecule.
-
We develop and refine analytical methods to meet the unique characteristics of your product. We focus on robustness, specificity, and reproducibility to ensure reliable performance across development phases. Our collaborative approach allows for rapid iteration and alignment with project scope and timelines.
-
Analytical methods are fine-tuned to maximize sensitivity, accuracy, robustness and efficiency. We evaluate critical parameters and adjust conditions to improve performance and reduce variability. Optimization ensures your methods are fit-for-purpose and scalable for future phases.
-
We perform comprehensive assessments to confirm that methods meet predefined criteria for accuracy, precision, linearity, and robustness. Qualification provides documented evidence of method reliability, reflecting regulatory expectations. This step prepares your analytics for smooth transfer into a GMP setting.
Formulation & Process Development
Development of formulation and drug product manufacturing processes:
- Liquid formulations
- Lyophilization formulations
- Lyophilization process
Primary Packaging Compatibility
Evaluation of compatibility with primary packaging materials:
- Vials
- Pre-filled syringes
- Cartridges
- and more!
In-Use Stability
Testing of clinical application setups:
- Liquid injection
- Liquid infusion
Our Services for Your Path to GMP
Coriolis offers a comprehensive GMP track for analytical method support, ensuring regulatory compliance and data integrity throughout the product lifecycle.
-
We establish and adapt analytical methods in alignment with regulatory expectations and product-specific requirements. This includes defining method parameters, setting preliminary acceptance criteria, and generating initial documentation. A structured approach ensures traceability and consistency from the outset.
-
Our method development under GMP conditions focuses on accuracy, robustness, specificity, and reproducibility. We tailor each method to the product’s critical quality attributes (CQAs) and process needs. This ensures reliable performance across different development stages.
-
We refine analytical methods to enhance performance and accuracy, reduce variability, and improve operational efficiency. Optimization under GMP ensures that methods are not only scientifically sound but also practical for routine use in clinical development and commercial manufacturing. This step supports long-term method sustainability.
-
Validation activities are tailored to the clinical phase and regulatory requirements. We apply a risk-based approach to demonstrate method suitability while maintaining flexibility for future adjustments. This ensures compliance without overburdening early-phase development.
-
We conduct full ICH-compliant validation to support product registration and commercial manufacturing. This includes comprehensive testing of accuracy, precision, linearity, range, and robustness. The resulting data package is audit-ready and supports global regulatory submissions.
-
We manage method transfer with a structured and documented approach, ensuring reproducibility at the receiving site. This includes transfer protocols, training, and comparative testing. Our goal is a smooth transition with minimal disruption to timelines or data integrity.
Release & Stability
Performance of release testing and stability testing under GMP conditions:
- ICH-compliant and supporting regulatory filings (IND, IMPD, BLA)
- Analytical methods to confirm identity, content, purity & potency.
- Standard and custom storage conditions.
Comparability
Evaluation of comparability under GMP conditions:
- ICH-compliant comparability exercise using validated release and stability methods
Analytical Testing
Testing of samples under GMP conditions:
- Drug substance
- Drug product
- Process intermediates
Methods available under GMP
We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.
Method Development and Validation Resources

Press Releases
Coriolis Pharma Opens New Laboratory at Spark Life Science Campus in Morrisville, North Carolina
July 22, 2025

Articles
Unlocking the Power of Analytical Ultracentrifugation (AUC) in Biopharmaceutical Development
June 18, 2025

Articles
May 19, 2025

Publications
Stability of Jurkat cells during short-term liquid storage analyzed by flow imaging microscopy
April 7, 2025